From Stephanie Woodcock, Carnon Downs, Cornwall, UK
Brandon Jutras’s hoped-for trial of the antibiotic piperacillin for human Lyme disease may rely on finding a sufficient cohort of people who get an early diagnosis. Many don’t, leaving them at risk of an incomplete treatment response. Moreover, it is concerning that the antibiotic primarily used now, doxycycline, could have been replaced with a superior, safe alternative long ago. Better late than never, I guess(3 May, p 11).
